Aura Biosciences (AURA) EBITDA (2020 - 2025)
Aura Biosciences (AURA) EBITDA from Mar 31, 2020 to Dec 31, 2025. The TTM Aura Biosciences (AURA) EBITDA is -$112M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Aura Biosciences (AURA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +17.67% |
| 3 Years TTM | +23.62% |
| 5 Years TTM | +39.18% |
| All Time TTM | +44.19% |
Annual EBITDA change of Aura Biosciences (AURA)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$112M | +17.67% |
| 2024 | -$95M | +13.37% |
| 2023 | -$84M | +41.58% |
| 2022 | -$59M | +71.76% |
| 2021 | -$34M | +61.07% |
| 2020 | -$21M | N/A |
Comparison Aura Biosciences (AURA) five years EBITDA CAGR with competitors
Aura Biosciences (AURA) five years EBITDA CAGR is 39.19%.